» Authors » Flora Sheng

Flora Sheng

Explore the profile of Flora Sheng including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 47
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stein B, Sheng F, Taylor E, Davis C, Griffin B, Sorbero M, et al.
Drug Alcohol Depend . 2025 Jan; 267():112533. PMID: 39823664
Importance: States have implemented multiple policies likely to influence opioid prescribing; few national general population studies examine those policies' effects on per-capita opioid morphine milligram equivalents (MME) dispensed. Objective: To...
2.
Ernecoff N, Sheng F, Cantor J, Stein B
J Am Geriatr Soc . 2024 Dec; PMID: 39630598
Background: Opioid use disorder (OUD) prevalence has increased threefold among Medicare beneficiaries 65 years and older (hereafter "older adults") since 2013, with a prevalence of 15.7 per 1000 Medicare beneficiaries...
3.
Stein B, Saloner B, Sheng F, Sorbero M, Dick A, Gordon A
J Gen Intern Med . 2024 Nov; PMID: 39543071
Importance: State policies facilitating telehealth implemented early in COVID may support buprenorphine treatment of opioid use disorder. However, little empirical information is available about those policies' effects. Objective: Examine association...
4.
Golan O, Sheng F, Dick A, Sorbero M, Whitaker D, Andraka-Christou B, et al.
Drug Alcohol Depend Rep . 2023 Oct; 9:100193. PMID: 37876376
Background: Although use of buprenorphine for treating opioid use disorder increased over the past decade, buprenorphine utilization remains limited in lower-income and rural areas. We examine how the Affordable Care...
5.
Harrison J, Sheng F, Josberger R, Liu H, Stone P, Luchsinger J, et al.
JAMA Netw Open . 2023 Jul; 6(7):e2322520. PMID: 37428503
Importance: New York State's Medicaid managed long-term care (MLTC) program expanded access to home- and community-based services, providing an alternative to nursing home care for people with dementia. Between 2012...
6.
Stein B, Saloner B, Golan O, Andraka-Christou B, Andrews C, Dick A, et al.
JAMA Health Forum . 2023 May; 4(5):e231102. PMID: 37234015
Importance: Expanding the use of buprenorphine for treating opioid use disorder is a critical component of the US response to the opioid crisis, but few studies have examined how state...
7.
Schulson L, Dick A, Sheng F, Stein B
J Gen Intern Med . 2023 Feb; 38(7):1681-1688. PMID: 36745303
Background: Insurance status may influence quality of opioid analgesic (OA) prescribing among patients seen by the same clinician. Objective: To explore how high-risk OA prescribing varies by payer type among...
8.
Stein B, Landis R, Sheng F, Saloner B, Gordon A, Sorbero M, et al.
J Gen Intern Med . 2022 Dec; 38(3):733-737. PMID: 36474004
Background: During the COVID pandemic, overall buprenorphine treatment appeared to remain relatively stable, despite some studies suggesting a decrease in patients starting buprenorphine. There is a paucity of empirical information...
9.
Stein B, Sheng F, Taylor E, Dick A, Sorbero M, Pacula R
Drug Alcohol Depend . 2022 Jan; 231:109232. PMID: 35007956
Background: Multiple state policies, such as prescription drug monitoring programs (PDMPs) and duration limits, have been implemented to decrease high-risk opioid prescribing. Studies demonstrate that many policies decrease certain opioid...
10.
Stein B, Taylor E, Sheng F, Dick A, Vaiana M, Sorbero M
Ann Intern Med . 2021 Dec; 175(2):299-302. PMID: 34958601
No abstract available.